Jasper Hellweg
Stock Analyst at Argus Research
(2.12)
# 2,922
Out of 5,129 analysts
92
Total ratings
48.61%
Success rate
3.6%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $360 → $400 | $364.65 | +9.69% | 1 | Feb 6, 2026 | |
| BAX Baxter International | Downgrades: Hold | n/a | $21.94 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $128.13 | +48.29% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $188.99 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $473.20 | -15.47% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $119.32 | +25.71% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $48.63 | +23.38% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $754.91 | +54.99% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $463.48 | +18.67% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $193.40 | -56.05% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $49.12 | +154.48% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $42.00 | +233.37% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $222.44 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $34.37 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $182.45 | +58.95% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $86.15 | +16.08% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $284.50 | +3.69% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.04 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $205.35 | -34.26% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.39 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $202.71 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $187.02 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $34.36 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $502.05 | -69.13% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $62.59 | +43.79% | 1 | Sep 19, 2018 |
Amgen
Feb 6, 2026
Maintains: Buy
Price Target: $360 → $400
Current: $364.65
Upside: +9.69%
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $21.94
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $128.13
Upside: +48.29%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $188.99
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $473.20
Upside: -15.47%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $119.32
Upside: +25.71%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $48.63
Upside: +23.38%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $754.91
Upside: +54.99%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $463.48
Upside: +18.67%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $193.40
Upside: -56.05%
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $49.12
Upside: +154.48%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $42.00
Upside: +233.37%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $222.44
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $34.37
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $182.45
Upside: +58.95%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $86.15
Upside: +16.08%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $284.50
Upside: +3.69%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $11.04
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $205.35
Upside: -34.26%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $14.39
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $202.71
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $187.02
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $34.36
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $502.05
Upside: -69.13%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $62.59
Upside: +43.79%